文献
J-GLOBAL ID:201802214366267095
整理番号:18A2153019
ESKDの代用終点としての蛋白尿,アルブミン尿,血清クレアチニンおよび推定GFRに対する薬物効果の妥当性:系統的レビュー【JST・京大機械翻訳】
The Validity of Drug Effects on Proteinuria, Albuminuria, Serum Creatinine, and Estimated GFR as Surrogate End Points for ESKD: A Systematic Review
著者 (8件):
Palmer Suetonia C.
(Department of Medicine, University of Otago, Christchurch, New Zealand)
,
Ruospo Marinella
(Diaverum Medical Scientific Office; Diaverum Academy, Lund, Sweden)
,
Teixeira-Pinto Armando
(Sydney School of Public Health, University of Sydney, NSW, Australia)
,
Craig Jonathan C.
(College of Medicine and Public Health, Flinders University, Adelaide, Australia)
,
Macaskill Petra
(Sydney School of Public Health, University of Sydney, NSW, Australia)
,
Strippoli Giovanni F.M.
(Diaverum Medical Scientific Office; Diaverum Academy, Lund, Sweden)
,
Strippoli Giovanni F.M.
(Sydney School of Public Health, University of Sydney, NSW, Australia)
,
Strippoli Giovanni F.M.
(Department of Emergency and Organ Transplantation, University of Bari, Italy)
資料名:
American Journal of Kidney Diseases
(American Journal of Kidney Diseases)
巻:
72
号:
6
ページ:
779-789
発行年:
2018年
JST資料番号:
A1201A
ISSN:
0272-6386
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)